Detalhe da pesquisa
1.
Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease.
Front Neuroendocrinol
; 73: 101122, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38346453
2.
Liraglutide Reduces Alcohol Consumption, Anxiety, Memory Impairment, and Synapse Loss in Alcohol Dependent Mice.
Neurochem Res
; 49(4): 1061-1075, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267691
3.
MCU knockdown in hippocampal neurons improves memory performance of an Alzheimer's disease mouse model.
Acta Biochim Biophys Sin (Shanghai)
; 54(10): 1528-1539, 2022 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239352
4.
The novel GLP-1/GIP dual agonist DA3-CH is more effective than liraglutide in reducing endoplasmic reticulum stress in diabetic rats with cerebral ischemia-reperfusion injury.
Nutr Metab Cardiovasc Dis
; 31(1): 333-343, 2021 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33500109
5.
Driving GABAergic neurons optogenetically improves learning, reduces amyloid load and enhances autophagy in a mouse model of Alzheimer's disease.
Biochem Biophys Res Commun
; 525(4): 928-935, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173530
6.
A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice.
Horm Behav
; 118: 104640, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31765661
7.
The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease.
J Pathol
; 245(1): 85-100, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29435980
8.
A novel GLP-1/GIP/Gcg triagonist reduces cognitive deficits and pathology in the 3xTg mouse model of Alzheimer's disease.
Hippocampus
; 28(5): 358-372, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29473979
9.
Defects in Peroxisomal 6-Phosphogluconate Dehydrogenase Isoform PGD2 Prevent Gametophytic Interaction in Arabidopsis thaliana.
Plant Physiol
; 171(1): 192-205, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26941195
10.
Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
Brain
; 139(Pt 3): 891-907, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26747862
11.
[GLP-1/GIP/Gcg receptor Triagonist improves the cognitive behaviors in triple-transgenic mice of Alzheimer's disease].
Sheng Li Xue Bao
; 69(2): 135-145, 2017 Apr 25.
Artigo
em Zh
| MEDLINE | ID: mdl-28435972
12.
Novel incretin analogues improve autophagy and protect from mitochondrial stress induced by rotenone in SH-SY5Y cells.
J Neurochem
; 139(1): 55-67, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27412483
13.
[Neuroprotective effects of a novel antidiabetic drug (D-Ser2)Oxm on amyloid ß protein-induced cytotoxicity].
Sheng Li Xue Bao
; 68(3): 265-75, 2016 Jun 25.
Artigo
em Zh
| MEDLINE | ID: mdl-27350199
14.
Neuroprotective effects of geniposide on Alzheimer's disease pathology.
Rev Neurosci
; 26(4): 371-83, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25879319
15.
Restoration of cerebral and systemic microvascular architecture in APP/PS1 transgenic mice following treatment with Liraglutide™.
Microcirculation
; 22(2): 133-45, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25556713
16.
Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress.
J Neurochem
; 128(3): 459-71, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24112036
17.
Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases.
Biochem Soc Trans
; 42(2): 593-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24646283
18.
First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease.
Alzheimers Dement
; 10(1 Suppl): S33-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24529523
19.
The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer's disease.
Alzheimers Dement
; 10(1 Suppl): S47-54, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24529525
20.
Drugs developed for treatment of diabetes show protective effects in Alzheimer's and Parkinson's diseases.
Sheng Li Xue Bao
; 66(5): 497-510, 2014 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331995